Yves Gélinas Selected Research

Obesity

12/2019	The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis.
5/2007	Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yves Gélinas Research Topics

Disease

3	Hyperlipidemias (Hyperlipidemia) 05/2007 - 11/2004
2	Obesity 12/2019 - 05/2007
2	Body Weight (Weight, Body) 12/2019 - 05/2007
2	Insulin Resistance 12/2018 - 11/2004
2	Hypercholesterolemia 05/2006 - 09/2005
2	Neoplasms (Cancer) 05/2006 - 09/2005
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Atherosclerosis 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Abdominal Obesity 05/2007
1	Weight Gain 05/2006

Drug/Important Bio-Agent (IBA)

3	CholesterolIBA 01/2019 - 09/2005
2	GlucocorticoidsIBA 05/2007 - 11/2004
2	Insulin (Novolin)FDA Link 04/2007 - 11/2004
2	PPAR gammaIBA 04/2007 - 11/2004
2	ritetroniumIBA 05/2006 - 09/2005
2	Estrogens (Estrogen)FDA Link 05/2006 - 09/2005
2	Selective Estrogen Receptor Modulators (SERM)IBA 05/2006 - 09/2005
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Serine (L-Serine)FDA Link 12/2018
1	Sucrose (Saccharose)IBA 05/2007
1	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 05/2007
1	Lipoproteins (Lipoprotein)IBA 05/2006
1	LDL Receptors (LDL Receptor)IBA 05/2006
1	Appetite Depressants (Anorectics)IBA 09/2005
1	LipidsIBA 11/2004

Therapy/Procedure

1	Ovariectomy (Oophorectomy) 05/2006